Abiopharma

🔍 Stahlin Paul (Director)

Company: Northfield Bancorp, Inc. (NFBK)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $13.19 per share (Direct)
  Date: 2026-03-17 | Code: P | equity_swap_involved: 0 | shares_owned_after: 54,354.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 4,383 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-17 | Code: H | shares_owned_after: 4,383.00 | Footnotes: F2, F3, F3

Footnotes:

• F1: The price reported in column 4 is a weighted average price. The shares were purchased at prices ranging from $13.13 to $13.20, inclusive. The reporting person undertakes to provide to Northfield Bancorp, Inc., any security holder of Northfield Bancorp, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
• F2: Each restricted stock unit represents a contingent right to receive cash equal to the value of one share of Issuer common stock on date of vesting.
• F3: Award vests one year from the date of grant.